Structure Therapeutics (GPCR) Share-based Compensation (2022 - 2026)

Structure Therapeutics' Share-based Compensation history runs 5 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 96.67% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $27.8 million (up 470.43% YoY), while the FY2025 annual figure was $29.0 million, up 1605.35% from the prior year.
• Share-based Compensation was $11.6 million for Q1 2026 at Structure Therapeutics, up from $8.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $11.6 million in Q1 2026 to a low of -$11.3 million in Q4 2024.
• Historically, Share-based Compensation has averaged $2.7 million across 5 years, with a median of $2.1 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation surged 308.55% in 2023, then tumbled 636.84% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $623000.0 in 2022, then soared by 236.76% to $2.1 million in 2023, then sank by 636.84% to -$11.3 million in 2024, then jumped by 171.64% to $8.1 million in 2025, then surged by 44.24% to $11.6 million in 2026.
• The last three Share-based Compensation figures came in at $11.6 million (Q1 2026), $8.1 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.